MoneyWorks4Me

Syschem (India) - Quaterly Results

06 May 2024 Evaluate
A decent increase of about 54.64% in the turnover to Rs. 880.02 millions was observed for the quarter ended March 2024. The turnover stood at Rs. 569.09 millions during the similar quarter previous year.The Net Loss for the quarter ended March 2024 is Rs. -2.64 millions as compared to Net Profit of Rs. 3.88 millions of corresponding quarter ended March 2023A decline of 17.69 millions was observed in the OP in the quarter ended March 2024 from 26.18 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 880.02 569.09 54.64 2334.77 1303.77 79.08 2334.77 1303.77 79.08
Other Income 1.51 0.99 52.53 1.70 2.48 -31.45 1.70 2.48 -31.45
PBIDT 17.69 26.18 -32.43 71.54 88.96 -19.58 71.54 88.96 -19.58
Interest 0.11 0.00 0.00 2.53 0.42 502.38 2.53 0.42 502.38
PBDT 17.58 26.18 -32.85 69.01 88.54 -22.06 69.01 88.54 -22.06
Depreciation 6.70 5.92 13.18 27.89 27.03 3.18 27.89 27.03 3.18
PBT 10.88 20.26 -46.30 41.12 61.51 -33.15 41.12 61.51 -33.15
TAX 13.52 16.38 -17.46 13.52 16.38 -17.46 13.52 16.38 -17.46
Deferred Tax 13.52 16.38 -17.46 13.52 16.38 -17.46 13.52 16.38 -17.46
PAT -2.64 3.88 -168.04 27.60 45.13 -38.84 27.60 45.13 -38.84
Equity 398.63 318.90 25.00 398.63 318.90 25.00 398.63 318.90 25.00
PBIDTM(%) 2.01 4.60 -56.30 3.06 6.82 -55.09 3.06 6.82 -55.09
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..